Impact of Prolonged Physical Therapy on Gait Performance of Chronic Phase Stroke Patients
NCT ID: NCT00658710
Last Updated: 2013-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
70 participants
INTERVENTIONAL
2008-06-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
patients who continue physical therapy sessions during two months.
physical therapy sessions
two physical therapy sessions per week for two months
2
patients who stop physical therapy sessions during two months
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
physical therapy sessions
two physical therapy sessions per week for two months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Finally, they must have a Functional Ambulation Classification (FAC) score between 4 and 6 during the inclusion.
Exclusion Criteria
* They must not have an associated cerebella syndrome or a clinical brainstem attack.
* We will refuse patients who are pregnant, who have not signed the written consent, and who aren't entitled to a social security scheme.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, France
OTHER_GOV
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascal Giraux, MD
Role: PRINCIPAL_INVESTIGATOR
CHU ST Etienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Régional de Réeducation et de Réadaptation Fonctionnelle
Angers, , France
Groupe hospitalier Pellegrin CHU Bordeaux
Bordeaux, , France
Hôpital J. Rebeyrol
Limoges, , France
Institut Régional de médecine physique et de Réadaptation
Nancy, , France
CHU de St Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-A00747-46
Identifier Type: -
Identifier Source: secondary_id
0701040
Identifier Type: -
Identifier Source: org_study_id